I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Peltola, Katriina
77
results:
Search for persons
X
Format
Online (75)
Print (1)
Mediatypes
Articles (Online) (25)
OpenAccess-fulltext (50)
Video (DVD/CD) (1)
Languages
german (1)
english (70)
more...
finnish (6)
less...
Sorted by: Relevance
Sorted by: Year
?
1
Venous thromboembolism incidence and association with overa..:
Aaltonen, Panu
;
Mustonen, Harri
;
Puolakkainen, Pauli
...
Cancer Medicine. 13 (2024) 14 - p. , 2024
Link:
https://doi.org/10.1002/..
?
2
Safety, Efficacy, and Biological Data of T-Cell–Enabling On..:
Pakola, Santeri A.
;
Peltola, Katriina J.
;
Clubb, James H.A.
...
Clinical Cancer Research. , 2024
Link:
https://doi.org/10.1158/..
?
3
42 Belzutifan versus everolimus for previously treated adva..:
Albiges, Laurence
;
Choueiri, Toni K
;
Peltola, Katriina
...
The Oncologist. 29 (2024) Supplement_1 - p. S3-S4 , 2024
Link:
https://doi.org/10.1093/..
?
4
Nivolumab monotherapy or combination with ipilimumab with o..:
Callahan, Margaret
;
Amin, Asim
;
Kaye, Frederic J
...
Journal for ImmunoTherapy of Cancer. 12 (2024) 2 - p. e007883 , 2024
Link:
https://doi.org/10.1136/..
?
5
Cholangitis and Interruptions of Neoadjuvant Chemotherapy A..:
Vehviläinen, Sini
;
Kuuliala, Antti
;
Udd, Marianne
...
Annals of Surgical Oncology. 31 (2023) 4 - p. 2621-2631 , 2023
Link:
https://doi.org/10.1245/..
?
6
Single-cell characterization of anti–LAG-3 and anti–PD-1 co..:
Huuhtanen, Jani
;
Kasanen, Henna
;
Peltola, Katriina
...
Journal of Clinical Investigation. 133 (2023) 6 - p. , 2023
Link:
https://doi.org/10.1172/..
?
7
Long-term nationwide trends in the treatment of and outcome..:
Aaltonen, Panu
;
Carpén, Olli
;
Mustonen, Harri
...
European Journal of Surgical Oncology. 48 (2022) 5 - p. 1087-1092 , 2022
Link:
https://doi.org/10.1016/..
?
8
Evolution and modulation of antigen-specific T cell respons..:
Huuhtanen, Jani
;
Chen, Liang
;
Jokinen, Emmi
...
Nature Communications. 13 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1038/..
?
9
First-in-human phase 1 study of budigalimab, an anti-PD-1 i..:
Italiano, Antoine
;
Cassier, Philippe A.
;
Lin, Chia-Chi
...
Cancer Immunology, Immunotherapy. 71 (2021) 2 - p. 417-431 , 2021
Link:
https://doi.org/10.1007/..
?
10
Gallbladder cancer epidemiology, treatment and survival in ..:
Koppatz, Hanna
;
Takala, Sini
;
Peltola, Katriina
...
Scandinavian Journal of Gastroenterology. 56 (2021) 8 - p. 929-939 , 2021
Link:
https://doi.org/10.1080/..
?
11
Safety, pharmacokinetics, and efficacy of budigalimab with ..:
Calvo, Emiliano
;
Spira, Alexander
;
Miguel, María de
...
Cancer Treatment and Research Communications. 28 (2021) - p. 100405 , 2021
Link:
https://doi.org/10.1016/..
?
12
Phase I/IIa, open-label, multicentre study to evaluate the ..:
Bono, Petri
;
Massard, Christophe
;
Peltola, Katriina J.
...
ESMO Open. 5 (2020) 6 - p. e001081 , 2020
Link:
https://doi.org/10.1136/..
?
13
Nivolumab versus everolimus in patients with advanced renal..:
Motzer, Robert J.
;
Escudier, Bernard
;
George, Saby
...
Cancer. 126 (2020) 18 - p. 4156-4167 , 2020
Link:
https://doi.org/10.1002/..
?
14
ODM-204, a Novel Dual Inhibitor of CYP17A1 and Androgen Rec..:
Peltola, Katriina J.
;
Bono, Petri
;
Jones, Robert Hugh
...
European Urology Focus. 6 (2020) 1 - p. 63-70 , 2020
Link:
https://doi.org/10.1016/..
?
15
ePROs in the follow-up of cancer patients treated with immu..:
Iivanainen, Sanna
;
Alanko, Tuomo
;
Peltola, Katriina
...
Journal of Cancer Research and Clinical Oncology. 145 (2019) 3 - p. 765-774 , 2019
Link:
https://doi.org/10.1007/..
1-15